microdosing semaglutide for perimenopause GLP-1: A Next-Generation Approach to Metabolic and Longevity Medicine: Shamsah Amersi, MD: OB-GYNs Struggling with stubborn belly fat

As Senior Director of Regulatory Affairs at Teva Pharmaceuticals USA, Inc., he leads regulatory strategy, submissions, and lifecycle management for complex generics spanning complex APIs, long acting injectables, respiratory therapies, combination products, and non sterile complex products

Leading CDMOs are becoming fully integrated partners managing complexity from formulation to device. News Medical, Why GLP-1 Manufacturing Needs a New Biopharma Approach, 2025 This shift is especially relevant for high-volume projects, where capacity planning and shared investment are critical to success

At the time of diagnosis of T2D in a patient with clinical ASCVD

1 Both are once-a-week injections with a similar dose schedule